top of page
Jillion_Logo_edited.png

Technology

Jillion's

Reinventing Drug Discovery

In-house synergies: Empowering Innovation with High-Power Screening (HPS) and DNA-Encoded Libraries

​

At Jillion Therapeutics, we harness the transformative power of High-Power Screening (HPS) combined with our own and proprietary DNA-Encoded Library (DEL) technologies. This potent synergy is the engine behind our relentless pursuit of novel therapeutics for complex neurological diseases.
 

High-Power Screening (HPS)

 

Jillion's team coined the term “HPS” in our review "High-power screening (HPS) empowered by DNA-encoded libraries" published in Trends in Pharmacological Sciences (2022 Jan; 43(1):4-15).

​​​​

 DEL enables the rapid, simultaneous screening of a vast number of real compounds in a single tube, within just a few days.

​

This large-scale screening significantly surpasses traditional HTS methods in both scope and efficiency.

​

By physically testing real compounds, synthesized in only 2 to 3 steps, DEL offers considerable advantages over in-silico screening approaches, delivering more reliable and actionable results.

Jillion_Logo (9).png

Synthetic organic chemistry: from DNA-Encoded Libraries (DELs) to off-DNA lead compounds

 

The cornerstone of our HPS system is the DNA-Encoded Library technology. We are designing and building our own focussed DEL libraries to reframe the way HPS is used.

​

Jillion’s deep expertise in organic chemistry, led by our Senior Chemist, ensures full control over the design and development of unique, focused DEL libraries, utilizing proprietary methods and internal know-how.

​

More importantly it enables the rapid in-house generation of drug-like compounds.

​

Hit & lead optimization through A.I.

​​

DELs are vast collections of small molecules where each compound is tagged with a unique DNA sequence that acts as a barcode. This ingenious coupling allows us to perform selections against targets of interest in ways that were not possible before. Swift decoding identities binding molecules through DNA sequencing (NGS).

​

DEL compounds, are real, easy and quick to synthetize, making them ideal drug-like compounds and a solid foundation for A.I. optimization.

bottom of page